切换至 "中华医学电子期刊资源库"

中华细胞与干细胞杂志(电子版) ›› 2019, Vol. 09 ›› Issue (04) : 193 -198. doi: 10.3877/cma.j.issn.2095-1221.2019.04.001

所属专题: 文献

论著

口腔鳞状细胞癌患者外周血Naa10及淋巴细胞免疫分型的特点及临床意义
曾旖1(), 张从纪1, 叶艳艳1, 郭俊峰2, 杨军1, 熊宇1,()   
  1. 1. 400038 重庆,陆军军医大学第一附属医院口腔科
    2. 400038 重庆,陆军军医大学基础医学院学员三大队
  • 收稿日期:2019-04-11 出版日期:2019-08-01
  • 通信作者: 曾旖, 熊宇
  • 基金资助:
    国家自然科学基金(81671022)

Characteristics and clinical significance of peripheral blood N-alpha-acetyltransferase 10 and lymphocyte immunophenotyping in patients with oral squamous cell carcinoma

Yi Zeng1,(), Congji Zhang1, Yanyan Ye1, Junfeng Guo2, Jun Yang1, Yu Xiong1()   

  1. 1. Department of Stomatology, First Affiliated Hospital of Army Military Medical University, Chongqing 400038, China
    2. The Third Military Corps of the Basic Medical College of the Army Military Medical University, Chongqing 400038, China
  • Received:2019-04-11 Published:2019-08-01
  • Corresponding author: Yi Zeng, Yu Xiong
  • About author:
    Corresponding author: Zeng Yi, Email:
引用本文:

曾旖, 张从纪, 叶艳艳, 郭俊峰, 杨军, 熊宇. 口腔鳞状细胞癌患者外周血Naa10及淋巴细胞免疫分型的特点及临床意义[J]. 中华细胞与干细胞杂志(电子版), 2019, 09(04): 193-198.

Yi Zeng, Congji Zhang, Yanyan Ye, Junfeng Guo, Jun Yang, Yu Xiong. Characteristics and clinical significance of peripheral blood N-alpha-acetyltransferase 10 and lymphocyte immunophenotyping in patients with oral squamous cell carcinoma[J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2019, 09(04): 193-198.

目的

探讨口腔鳞状细胞癌(OSCC)患者外周血N-α-乙酰基转移酶10 (Naa10)及淋巴细胞免疫分型的特点,并分析其临床意义。

方法

选取97例OSCC患者及50名健康体检者,分别纳入患者组、对照组。检测两组受试者外周血Naa10、淋巴细胞免疫分型,并比较不同TNM分期、不同淋巴结转移状态患者外周血Naa10、淋巴细胞免疫分型的差异,总结其特点与临床意义。不同性别人数采用χ2检验,计量资料行正态性检验,满足正态性且组间方差相等则采用t检验,不满足正态性则采用非参数Wilcoxon秩和检验,相关性分析采用Pearson法。

结果

患者组血清Naa10为(62.91±17.15)pg/ml,高于对照组的(38.82±9.04)pg/ml,差异有统计学意义(t?= 9.280,P?< 0.05)。患者组CD3+、CD4+、CD4+/CD8+、NK细胞百分比分别为(71.63±9.11)﹪、(34.34±4.26)﹪、(1.03±0.28)、(14.23±4.61)﹪,低于对照组的(76.25±2.87)﹪、(45.41±7.08)﹪、(1.77± 0.39)、(19.96±5.13)﹪,CD8+、B淋巴细胞百分比分别为(14.23±4.61)﹪、(14.91±3.29)﹪,高于后者的(19.96±5.13)﹪、(9.11±2.60)﹪,差异有统计学意义(P?< 0.05)。TNM分期Ⅰ~Ⅱ期患者42例,其血清Naa10为(64.08±15.26)?pg/?ml,与Ⅲ~Ⅳ期患者的(61.71±13.15)pg/ml比较,差异无统计学意义(t?= 0.820,P?> 0.05)。淋巴结转移者34例,其血清Naa10为(65.15±14.07)pg/ml,与无淋巴结转移者的(61.45±12.66)?pg/?ml比较,差异无统计学意义(t?= 1.321,P?> 0.05)。Ⅰ~Ⅱ期患者CD3+、CD4+、CD4+/CD8+、NK细胞百分比低于Ⅲ~Ⅳ期患者,其CD8+、B淋巴细胞百分比高于后者,差异有统计学意义(P?< 0.05)。Pearson相关性分析示,外周血Naa10与CD3+ (-0.631)、CD4+ (-0.529)、CD4+/CD8+ (-0.587)、NK细胞百分比(-0.603)呈负相关,与CD8+ (0.558)、B淋巴细胞百分比(0.670)呈正相关(P?< 0.05)。

结论

OSCC患者外周血Naa10明显升高但与TNM分期、淋巴结转移无关;其淋巴细胞免疫分型存在明显改变,且TNM分期的上升、淋巴结转移的发生伴随着CD3+、CD4+、CD4+/?CD8+、NK细胞百分比的下降,以及CD8+、B淋巴细胞百分比的上升。

Objective

To analyze the characteristics of peripheral blood N-alpha-acetyltransferase 10 (Naa10) and lymphocyte immunophenotyping in patients with oral squamous cell carcinoma (OSCC) and to explore its clinical significance.

Methods

97 OSCC patients and 50 health examinees were enrolled in the patient group and the control group respectively. Naa10 and lymphocyte immunophenotyping in the peripheral blood of the two groups were detected. The differences of Naa10 and lymphocyte immunophenotyping in the peripheral blood of patients with different TNM stages and lymph node metastasis status were compared, and their characteristics and clinical significance were summarized.

Results

The serum Naa10 in the patients group was (62.91±17.15) pg/ml, which was higher than that in the control group (38.82±9.04) pg/ml (t?= 9.280, P?< 0.05) . The percentages of CD3+, CD4+, CD4+/CD8+, NK cells in the patients group were (71.63±9.11) ﹪, (34.34±4.26) ﹪, (1.03±0.28) and (14.23±4.61) ﹪, which were lower than those in the control group (76.25±2.87) ﹪, (45.41±7.08) ﹪, (1.77±0.39) and (19.96±5.13) ﹪. The percentages of CD8+, B lymphocyte in the patients group were (14.23±4.61) ﹪, (14.91±3.29) ﹪, which were higher than those in the latter group (19.96±5.13) ﹪, (9.11±2.60) ﹪. The serum Naa10 of 42 patients with TNM stageⅠ~Ⅱwas (64.08±15.26) pg/mL. There was no significant difference between the serum Naa10 and the serum Naa10 of patients with TNM stage Ⅲ~Ⅳ (61.71±13.15) pg/ml (t?= 0.820, P?> 0.05) . There were 34 cases with lymph node metastasis, and the serum Naa10 was (65.15 ±14.07) ?pg/ml. There was no significant difference between those without lymph node metastasis and those without lymph node metastasis (61.45±12.66) pg/ml (t?= 1.321, P?> 0.05) . The percentages of CD3+, CD4+, CD4+/CD8+, NK cells in stageⅠ~Ⅱ patients were lower than those in stage Ⅲ~Ⅳ patients, and the percentages of CD8+, B lymphocyte in stageⅠ~Ⅱpatients were higher than those in stage Ⅲ~Ⅳ patients (P?< 0.05) . Pearson correlation analysis showed that Naa10 in peripheral blood was negatively correlated with CD3+ (-0.631) , CD4+ (-0.529) , CD4+/CD8+ (-0.587) , percentage of NK cells (-0.603) , and positively correlated with CD8+ (0.558) and percentage of B lymphocyte (0.670) (P?< 0.05) .

Conclusion

Naa10 in peripheral blood of OSCC patients was increased significantly, but not related to TNM stage and lymph node metastasis. The lymphocyte immunophenotype of OSCC patients changed significantly, and the increase of TNM stage and lymph node metastasis was accompanied by the decrease of CD3+, CD4+, CD4+/CD8+, NK cell percentage and the increase of CD8+, B lymphocyte percentage.

图1 患者组(左)与对照组(右)淋巴细胞免疫分型对比
表1 患者组与对照组淋巴细胞免疫分型检测结果( ± s
图2 不同TNM分期Ⅰ~Ⅱ期(左)和Ⅲ~Ⅳ期(右)患者淋巴细胞免疫分型对比
表2 不同TNM分期患者淋巴细胞免疫分型检测结果( ± s
图3 有淋巴结转移(左)和无淋巴结转移(右)患者淋巴细胞免疫分型对比
表3 不同淋巴结转移状态患者淋巴细胞免疫分型检测结果( ± s
表4 外周血Naa10与淋巴细胞免疫分型的相关性分析
1
Nguyen N, Bellile E, Thomas D, et al. Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma[J]. Head Neck, 2016, 38(7):1074-1084.
2
马超, 赵继志, 张韬, 等. 细胞黏附分子-1和淋巴细胞功能相关抗原在口腔鳞癌中的表达及其临床意义[J]. 中国药物与临床, 2015, 15(9):1337-1339.
3
Nakashima H, Matsuoka Y, Yoshida R, et al. Pre-treatment neutrophil to lymphocyte ratio predicts the chemoradiotherapy outcome and survival in patients with oral squamous cell carcinoma: a retrospective study[J]. BMC Cancer, 2016, 16:41.
4
李怡宁, 陈思远, 胡济安. O-糖基化在口腔鳞状细胞癌发生发展中的作用初探[J]. 口腔生物医学, 2015, 6(4):172-177.
5
Chen S, Guo JB, Feng CJ, et al. The preoperative platelet-lymphocyte ratio versus neutrophil-lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma?[J]. Ther Adv Med Oncol, 2016, 8(3):160-167.
6
Wolf GT, Chepeha DB, Bellile E, et al. Tumor infiltrating lymphocytes (TIL) and prognosis in oral cavity squamous carcinoma: A preliminary study[J]. Oral Oncol, 2015, 51(1):90-95.
7
Straub M, Drecoll E, Pfarr N, et al. CD274/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity[J]. Oncotarget, 2016, 7(11):12024-12034.
8
余芯乐, 郑军, 徐江, 等. 口腔鳞状细胞癌患者唾液和血清中N-α-乙酰基转移酶10的水平及其临床意义[J]. 国际口腔医学杂志, 2018, 45(4):391-395.
9
Wirsing AM, Rikardsen OG, Steigen SE, et al. Presence of tumour high-endothelial venules is an Independent positive prognostic factor and stratifies patients with advanced-stage oral squamous cell carcinoma[J]. Tumor Biol, 2016, 37(2):2449-2459.
10
孙晓静. 口腔鳞状细胞癌患者治疗前后外周血免疫细胞的检测及其临床意义的研究[D]. 郑州: 郑州大学, 2017.
11
Wirsing AM, Ervik IK, Seppola M, et al. Presence of high-endothelial venules correlates with a favorable immune microenvironment in oral squamous cell carcinoma[J]. Mod Pathol, 2018, 31(6):910-922.
12
Rassouli A, Saliba J, Castano R, et al. Systemic inflammatory markers as Independent prognosticators of head and neck squamous cell carcinoma[J]. Head Neck, 2015, 37(1):103-110.
13
郑军, 徐江, 余芯乐, 等. N-乙酰基转移酶10蛋白和朊蛋白在口腔鳞状细胞癌组织中的表达及相关性研究[J]. 口腔医学研究, 2016, 32(5):483-486.
14
Satgunaseelan L, Gupta R, Madore J, et al. Programmed cell death-ligand 1 expression in oral squamous cell carcinoma is associated with an inflammatory phenotype[J]. Pathology, 2016, 48(6):574-580.
15
杨柳, 陈娟, 单忠艳, 等. 口腔鳞状细胞癌患者外周血淋巴细胞免疫分型及临床意义[J]. 口腔医学研究, 2018, 34(5):93-98.
16
Groeger S, Howaldt HP, Raifer H, et al. Oral squamous carcinoma cells Express B7-H1 and B7-DC receptors in vivo[J]. Pathol Oncol Res, 2017, 23(1):99-110.
17
Farhan-Alanie OM. McMahon J, McMillan DC. Systemic inflammatory response and survival in patients undergoing curative resection of oral squamous cell carcinoma[J]. Br J Oral Maxillofacl Surg, 2015, 53(2):126-131.
18
Kogashiwa Y, Yasuda M, Sakurai HA, et al. PD-L1 expression confers better prognosis in locally advanced oral squamous cell carcinoma[J]. Anticancer Res, 2017, 37(3):1417-1424.
[1] 王亚萍, 樊菁, 侯牛牛, 凌瑞. 肿瘤浸润性淋巴细胞在HER-2阳性早期乳腺癌中的临床意义[J]. 中华乳腺病杂志(电子版), 2023, 17(04): 203-209.
[2] 罗晨, 宗开灿, 李世颖, 傅应亚. 微小RNA-199a-3p调控CD4T细胞表达参与肺炎支原体肺炎患儿免疫反应研究[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 569-574.
[3] 韩春颖, 王婷婷, 李艳艳, 朴金霞. 子宫内膜癌患者淋巴管间隙浸润预测因素研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 403-409.
[4] 崔键, 戴庆. 基于肝囊型包虫病所致过敏反应模型研究Treg细胞数量比例与过敏反应的关系[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 427-430.
[5] 孟锦雯, 刘治坤, 顾钰峰, 王建国, 杨帆, 郑树森, 徐骁. 基于卷积神经网络的肝细胞癌复发预警数字病理学模型研究[J]. 中华肝脏外科手术学电子杂志, 2023, 12(03): 272-277.
[6] 于小鹏, 陈晨, 陈家璐, 童焕军, 邱应和, 吴泓, 宋天强, 何宇, 毛先海, 翟文龙, 程张军, 李敬东, 耿智敏, 汤朝晖. 肝内胆管细胞癌淋巴结清扫患者生存获益的术前临床病理特征[J]. 中华肝脏外科手术学电子杂志, 2023, 12(03): 278-283.
[7] 夏普开提·甫拉提, 吐尔洪江·吐逊, 温浩, 姚刚. 术前血小板与淋巴细胞比值对肝切除术后肝衰竭的预测价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(03): 289-293.
[8] 王娟, 高俊, 周伊兰, 李小红, 史兵伟, 潘美珍. 血清IL-2、IL-17和骨密度关系及其对骨质疏松症的预测价值[J]. 中华老年骨科与康复电子杂志, 2023, 09(05): 295-300.
[9] 陈科春, 吴秋义, 李建, 周寅, 徐周. 基于不同中性粒细胞与淋巴细胞比值探讨机械取栓术后首次CT征象与患者预后的关系[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(04): 215-221.
[10] 王庆, 夏婷婷. 未成熟粒细胞计数、C反应蛋白、中性粒细胞/淋巴细胞、降钙素原结合MCTSI评分在急性胆源性胰腺炎中的诊断价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(04): 224-228.
[11] 吴萌, 吴国仲, 王贵红, 端靓靓, 施杰, 王旭, 余婷, 刘伟. IgA肾病患者中性粒细胞-淋巴细胞比值与肾小管萎缩/间质纤维化相关性分析[J]. 中华临床医师杂志(电子版), 2023, 17(9): 972-979.
[12] 符梅沙, 周玉华, 李慧, 薛春颜. 淋巴细胞免疫治疗对复发性流产患者外周血T淋巴细胞亚群分布与PD1/PD-L1表达的影响及意义[J]. 中华临床医师杂志(电子版), 2023, 17(06): 726-730.
[13] 牛文博, 吴凤鹏, 刘月平, 周超熙, 张娟, 胡旭华, 李保坤, 王贵英. 新辅助放化疗对局部进展期直肠癌疗效及肿瘤免疫微环境变化的研究[J]. 中华临床医师杂志(电子版), 2023, 17(05): 519-523.
[14] 范茹, 刘宇清, 胡晓榕, 王轶奇, 张芬, 岑星, 卜玉洁, 陈俊伟. 系统性红斑狼疮患者长链非编码RNA表达变化及其与CD8+T细胞相关性研究[J]. 中华诊断学电子杂志, 2023, 11(03): 184-189.
[15] 刘玉苓, 王婷婷, 吴高峰, 俞淑静. 健康体检人群内脏脂肪面积与新型炎症标志物的相关性研究[J]. 中华肥胖与代谢病电子杂志, 2023, 09(03): 197-202.
阅读次数
全文


摘要